2 items2 sources1 stocks
Seeking Alpha-Nov 6, 02:45 AM
Castle Biosciences signals $385M-$395M 2026 revenue outlook as TissueCypher targets 50%-52% volume growth
Castle Biosciences signals $385M-$395M 2026 revenue outlook as TissueCypher targets 50%-52% volume growth(摘要待生成)
The Motley Fool-Nov 6, 07:09 AM
Castle Bio (CSTL) Q3 2026 Earnings Call Transcript
Castle Bio (CSTL) Q3 2026 Earnings Call Transcript(摘要待生成)